These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20632180)

  • 1. [Advances in pediatric and adolescent rheumatology: national and international cooperation].
    Huppertz HI
    Z Rheumatol; 2010 Aug; 69(6):486-7. PubMed ID: 20632180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rheumatology today - a dynamic discipline for the patients' good].
    Schulze-Koops H; Blum HE
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1651. PubMed ID: 21833883
    [No Abstract]   [Full Text] [Related]  

  • 3. The British Society for Rheumatology Biologics Register: 6 years on.
    Hyrich KL; Watson KD; Isenberg DA; Symmons DP;
    Rheumatology (Oxford); 2008 Oct; 47(10):1441-3. PubMed ID: 18596052
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporin in pediatric rheumatology; a seven years experience.
    Gattinara M; Lomater C; Gerloni V; Mazzotti J; Fantini F
    Acta Univ Carol Med (Praha); 1994; 40(1-4):105-8. PubMed ID: 9355683
    [No Abstract]   [Full Text] [Related]  

  • 5. Rheumatoid arthritis.
    Lorenzo M
    Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials in pediatric rheumatology: comment on the editorial by Lehman.
    DeWitt EM; Ardoin SP; Rabinovich CE; Schanberg LE
    Arthritis Rheum; 2008 Apr; 58(4):1202-3; author reply 1203. PubMed ID: 18383362
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of medications used in juvenile rheumatoid arthritis.
    Guthrie B; Rouster-Stevens KA; Reynolds SL
    Pediatr Emerg Care; 2007 Jan; 23(1):38-46. PubMed ID: 17228221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile idiopathic arthritis--current and future therapies.
    Kahn P
    Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals.
    Beresford MW; Baildam EM
    Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):151-6. PubMed ID: 19770495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biologic agents in juvenile idiopathic arthritis].
    Gomes JA
    Acta Reumatol Port; 2007; 32(1):13-4. PubMed ID: 17450760
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interdisciplinary cooperation essential. Hand in hand against rheumatic disease].
    Stiefelhagen P
    MMW Fortschr Med; 2013 Feb; 155(2):14-5. PubMed ID: 23573734
    [No Abstract]   [Full Text] [Related]  

  • 13. Juvenile idiopathic arthritis: state of the art and future perspectives.
    Martini A; Lovell DJ
    Ann Rheum Dis; 2010 Jul; 69(7):1260-3. PubMed ID: 20525835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of juvenile rheumatoid arthritis.
    Bloom B
    Med Health R I; 1999 Sep; 82(9):329-31. PubMed ID: 10517078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint approach.
    Palmer K
    Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
    [No Abstract]   [Full Text] [Related]  

  • 16. Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate.
    Londino AV; Blatt J; Knisely AS
    J Rheumatol; 1998 Jun; 25(6):1245-6. PubMed ID: 9632099
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of early rheumatoid arthritis].
    Iking-Konert C; Ostendorf B; Schneider M
    Med Monatsschr Pharm; 2007 Mar; 30(3):94-100; quiz 101. PubMed ID: 17405482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.
    Bathon JM; Cohen SB
    Arthritis Rheum; 2008 Jun; 59(6):757-9. PubMed ID: 18512712
    [No Abstract]   [Full Text] [Related]  

  • 19. BIOBADASER, BIOBADAMERICA, and BIOBADADERM: safety registers sharing commonalities across diseases and countries.
    Carmona L; de la Vega M; Ranza R; Casado G; Titton DC; Descalzo MÁ; Gómez-Reino J
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-163-7. PubMed ID: 25365109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
    Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
    Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.